Aerpio Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, March 5, 2019

CINCINNATI--(BUSINESS WIRE)--Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced that its fourth quarter and full year 2018 financial results will be released before the market opens on Tuesday, March 5, 2019. Following the release, the Company will host a live conference call and webcast at 8:30 a.m. EST to discuss the Company’s financial results and provi

Full Story →